Logo 235 Pill - yellow round, 7mm
Generic Name: gilteritinib
Pill with imprint Logo 235 is Yellow, Round and has been identified as Xospata 40 mg. It is supplied by Astellas Pharma US, Inc.
Xospata is used in the treatment of Acute Myeloid Leukemia and belongs to the drug class multikinase inhibitors. Xospata 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo 235
Xospata
- Generic Name
- gilteritinib
- Imprint
- Logo 235
- Strength
- 40 mg
- Color
- Yellow
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Astellas Pharma US, Inc.
- National Drug Code (NDC)
- 00469-1425
Related images for "Logo 235"
More about Xospata (gilteritinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.